Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2010

01-10-2010 | Brief Report

Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision

Authors: Isacco Montroni, Donatella Santini, Giorgia Zucchini, Monica Fiacchi, Simone Zanotti, Giampaolo Ugolini, Alessio Manaresi, Mario Taffurelli

Published in: Breast Cancer Research and Treatment | Issue 3/2010

Login to get access

Abstract

Nipple discharge (ND) is a common symptom seen in breast cancer clinics. The primary aim of this study was to identify preoperative risk factors for breast cancer in patients with pathologic ND. The secondary aim was to assess the clinical and pathological effectiveness of physical examination, galactography, cytological examination of the discharge, selective duct excision and ductoscopy. All patients operated on between 1975 and 2008 who presented with ND as their only symptom was analyzed. Discharge’s characteristics, cytological data and galactography reports were recorded. The relationship between each individual finding and the risk of breast cancer was calculated. For each diagnostic tool, the sensitivity, specificity and complication rates were calculated and compared. Nine-hundred-fifteen patients underwent selective duct excision. Two-hundred-nineteen patients (23.9%) were found to be affected by carcinoma. In 100/330 (30.3%) patients with bloody discharge and in 42/239 (17.6%) patients with serous secretion cancer was detected (P = 0.004, P = 0.013, respectively). Patients with sero-sanguinous or coloured discharge had the same risk of cancer as the population analyzed (23.9%, P = NS). Galactographic finding of irregular stenosis seemed to be associated with a higher risk of cancer (P = 0.0001). Cytological findings C5 and C4 were associated with cancer (P = 0.001). Selective duct excision showed highest sensitivity and specificity. In conclusion, the well established role of bloody secretion is confirmed. The supposed benign aetiology of serous, coloured or sero-sanguinous discharge is questionable. The high specificity of the cytological exam justifies routine examination of the ND. Selective duct excision can be considered as the diagnostic gold-standard.
Literature
1.
go back to reference Gulay H, Bora S, Kilicturgay S et al (1994) Management of nipple discharge. J Am Coll Surg 178:471–474PubMed Gulay H, Bora S, Kilicturgay S et al (1994) Management of nipple discharge. J Am Coll Surg 178:471–474PubMed
2.
go back to reference Murphy IG, Dillon MF, O’Doherty A et al (2007) Analysis of patients with false negative mammography and symptomatic breast carcinoma. J Surg Oncol 96:457–463CrossRefPubMed Murphy IG, Dillon MF, O’Doherty A et al (2007) Analysis of patients with false negative mammography and symptomatic breast carcinoma. J Surg Oncol 96:457–463CrossRefPubMed
3.
go back to reference Vargas HI, Vargas MP, Eldrageely K et al (2006) Outcomes of clinical and surgical assessment of women with pathological nipple discharge. Am Surg 72:124–128PubMed Vargas HI, Vargas MP, Eldrageely K et al (2006) Outcomes of clinical and surgical assessment of women with pathological nipple discharge. Am Surg 72:124–128PubMed
4.
go back to reference Hussain AN, Policarpio C, Vincent MT (2006) Evaluating nipple discharge. Obstet Gynecol Surv 61:278–283CrossRefPubMed Hussain AN, Policarpio C, Vincent MT (2006) Evaluating nipple discharge. Obstet Gynecol Surv 61:278–283CrossRefPubMed
5.
go back to reference Sauter ER, Schlatter L, Lininger J et al (2004) The association of bloody nipple discharge with breast pathology. Surgery 136:780–785CrossRefPubMed Sauter ER, Schlatter L, Lininger J et al (2004) The association of bloody nipple discharge with breast pathology. Surgery 136:780–785CrossRefPubMed
6.
go back to reference Simmons R, Adamovich T, Brennan M et al (2003) Nonsurgical evaluation of pathologic nipple discharge. Ann Surg Oncol 10:113–116CrossRefPubMed Simmons R, Adamovich T, Brennan M et al (2003) Nonsurgical evaluation of pathologic nipple discharge. Ann Surg Oncol 10:113–116CrossRefPubMed
7.
go back to reference Parkin DM, Bray F, Ferlay J et al (2002) Global cancer statistics. CA Cancer J Clin 55(2):74–108CrossRef Parkin DM, Bray F, Ferlay J et al (2002) Global cancer statistics. CA Cancer J Clin 55(2):74–108CrossRef
8.
go back to reference King TA, Carter KM, Bolton JS et al (2000) A simple approach to nipple discharge. Am Surg 66:960–966PubMed King TA, Carter KM, Bolton JS et al (2000) A simple approach to nipple discharge. Am Surg 66:960–966PubMed
9.
10.
go back to reference Kapenhas-Valdes E, Feldman SM, Boolbol SK (2008) The role of mammary ductoscopy in breast cancer: a review of the literature. Ann Surg Oncol 15:3350–3360CrossRefPubMed Kapenhas-Valdes E, Feldman SM, Boolbol SK (2008) The role of mammary ductoscopy in breast cancer: a review of the literature. Ann Surg Oncol 15:3350–3360CrossRefPubMed
11.
go back to reference Dixon JM, Mansel RE (1994) ABC of breast diseases: symptoms assessment and guidelines for referral. BMJ 309:722–726PubMed Dixon JM, Mansel RE (1994) ABC of breast diseases: symptoms assessment and guidelines for referral. BMJ 309:722–726PubMed
12.
go back to reference Adepoju LJ, Chun J, El-Tamer M et al (2005) The value of clinical characteristics and breast-imaging studies in predicting a histopathologic diagnosis of cancer or high risk lesion in patients with spontaneous nipple discharge. Am J Surg 190:644–646CrossRefPubMed Adepoju LJ, Chun J, El-Tamer M et al (2005) The value of clinical characteristics and breast-imaging studies in predicting a histopathologic diagnosis of cancer or high risk lesion in patients with spontaneous nipple discharge. Am J Surg 190:644–646CrossRefPubMed
13.
go back to reference Dinkel HP, Gassel AM, Muller T et al (2001) Galactography and exfoliative cytology in women with abnormal nipple discharge. Obstet Gynecol 97:625–629CrossRefPubMed Dinkel HP, Gassel AM, Muller T et al (2001) Galactography and exfoliative cytology in women with abnormal nipple discharge. Obstet Gynecol 97:625–629CrossRefPubMed
14.
go back to reference Florio MG, Manganaro T, Pollicino A et al (1999) Surgical approach to nipple discharge: a ten-year experience. J Surg Oncol 71:235–238CrossRef Florio MG, Manganaro T, Pollicino A et al (1999) Surgical approach to nipple discharge: a ten-year experience. J Surg Oncol 71:235–238CrossRef
15.
go back to reference Locker AP, Galea MH, Ellis IO et al (1988) Microdochectomy for single duct discharge from the nipple. Br J Surg 75:700–701CrossRefPubMed Locker AP, Galea MH, Ellis IO et al (1988) Microdochectomy for single duct discharge from the nipple. Br J Surg 75:700–701CrossRefPubMed
16.
go back to reference Masanori H, Hiroshi N, Takehiko G (2007) MR ductography: comparison with conventional ductography as a diagnostic method in patients with nipple discharge. RadioGraphics 27:183–196CrossRef Masanori H, Hiroshi N, Takehiko G (2007) MR ductography: comparison with conventional ductography as a diagnostic method in patients with nipple discharge. RadioGraphics 27:183–196CrossRef
17.
go back to reference National Task Force for Breast Cancer Autori (2007) FONCAM guidelines for breast pathology. Florence, Italy. Mancano le pagine National Task Force for Breast Cancer Autori (2007) FONCAM guidelines for breast pathology. Florence, Italy. Mancano le pagine
18.
go back to reference Louie LD, Crowe JP, Dawson AE et al (2006) Identification of breast cancer in patients with pathologic nipple discharge: does ductoscopy predict malignancy? Am J Surg 192(4):530–533CrossRefPubMed Louie LD, Crowe JP, Dawson AE et al (2006) Identification of breast cancer in patients with pathologic nipple discharge: does ductoscopy predict malignancy? Am J Surg 192(4):530–533CrossRefPubMed
19.
go back to reference Hunerbein M, Dubowy A, Raubach M et al (2007) Gradient index ductoscopy and intraductal biopsy of intraductal breast lesions. Am J Surg 194:511–514CrossRefPubMed Hunerbein M, Dubowy A, Raubach M et al (2007) Gradient index ductoscopy and intraductal biopsy of intraductal breast lesions. Am J Surg 194:511–514CrossRefPubMed
20.
21.
go back to reference Lang JE, Kuerer HM (2007) Breast ductal secretions: clinical features, potential uses, and possible applications. Cancer Control 14(4):350–359PubMed Lang JE, Kuerer HM (2007) Breast ductal secretions: clinical features, potential uses, and possible applications. Cancer Control 14(4):350–359PubMed
22.
go back to reference Pritt B, Pang Y, Kellogg M et al (2004) Diagnostic value of nipple cytology: study of 466 cases. Cancer 102(4):233–238CrossRefPubMed Pritt B, Pang Y, Kellogg M et al (2004) Diagnostic value of nipple cytology: study of 466 cases. Cancer 102(4):233–238CrossRefPubMed
23.
go back to reference Kooistra BW, Wauters C, van de Ven S et al (2009) The diagnostic value of nipple discharge cytology in 618 consecutive patients. Eur J Surg Oncol 35(6):573–577PubMed Kooistra BW, Wauters C, van de Ven S et al (2009) The diagnostic value of nipple discharge cytology in 618 consecutive patients. Eur J Surg Oncol 35(6):573–577PubMed
Metadata
Title
Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision
Authors
Isacco Montroni
Donatella Santini
Giorgia Zucchini
Monica Fiacchi
Simone Zanotti
Giampaolo Ugolini
Alessio Manaresi
Mario Taffurelli
Publication date
01-10-2010
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2010
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-010-0815-1

Other articles of this Issue 3/2010

Breast Cancer Research and Treatment 3/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine